Judge Rules Biogen Must Face Federal Portion of FCA Complaint

A Massachusetts judge ruled that Biogen must face a False Claims Act lawsuit brought by former employees alleging the company paid healthcare providers kickbacks to prescribe Biogen’s multiple sclerosis products, including Avonex, Tecfidera and Tysabri.
Source: Drug Industry Daily